(1)
Olivari, E. Addition of Daratumumab to First-Line Therapy of Newly Diagnosed Multiple Myeloma in Patients Eligible for Autologous Stem Cell Transplantation: A Single-Center Real-Life Experience. Mediterr J Hematol Infect Dis 2025, 17, e2025040.